Commentary
A. de Gottardi et al. (Gastroenterology and Hepatology, Ente Ospedaliero Cantonale, Lugano, Switzerland) present a case of SARS-CoV-2 infection reported in the literature in a liver transplanted patient. In this immunosuppressed patient, the evolution of the infection was characterized by a moderate to severe interstitial pneumonia over a period of 10 days with a minimal initial increase of ALT.
The findings presented in this article confirm that the liver may be only mildly affected during SARS-CoV-2 infection and suggest that this is also true in liver transplanted patients.
Previous Post
Differential effects of selective- and pan-PPAR agonists on experimental steatohepatitis and hepatic macrophages.
Next Post
Metabolic Liver Disease in Diabetes - from Mechanisms to Clinical Trials